Westin JR, Kersten MJ, Salles G, Abramson JS, et al. Efficacy and safety of CD19-directed CAR-T cell therapies in patients with relapsed/refractory aggressive B-cell lymphomas: Observations from the JULIET, ZUMA-1, and TRANSCEND trials. Am J Hematol 2021;96:1295-1312.
PMID: 34310745